ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:
| 1. | Details of the person discharging managerial responsibility / person closely associated | ||
| a) | Name | Henrik Jacobi | |
| 2. | Reason for the notification | ||
| a) | Position/status | Member of the Board of Management | |
| b) | Initial notification/ amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | ALK-Abelló A/S | |
| b) | LEI | 529900SGCREUZCZ7P020 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares DK0060027142 | |
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 2,621 | 3,200 | ||
| d) | Aggregated information - Aggregated volume - Price | 3,200 DKK 8,388,170 | |
| e) | Date of the transaction | 2021-03-02 | |
| f) | Place of the transaction | Nasdaq Copenhagen | |
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, mobile +45 2261 2525
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Constellation Brands, Inc.7.1.2026 22:05:00 CET | Press release
Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results
Oil-Dri Corporation Of America7.1.2026 22:00:00 CET | Press release
Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026
DBV Technologies S.A.7.1.2026 22:00:00 CET | Press release
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
King Faisal Prize7.1.2026 19:01:34 CET | Press release
Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize
Herantis Pharma plc7.1.2026 19:01:06 CET | Press release
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
